medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2018-21-146-151medsovet-2829Research ArticleДЕРМАТОЛОГИЯDERMATOLOGYВопросы этапности наружной терапии микозов кожи стопIssues of stage-by-stage approach to the external therapy of foot skin mycosisЯковлевА. Б.YakovlevA. В.

Яковлев Алексей Борисович – кандидат медицинских наук, доцент кафедры дерматовенерологии и косметологии

121359, г. Москва, ул. Маршала Тимошенко д. 19, стр. 1А

Yakovlev Alexey Borisovich – Cand. of Sci. (Med.), Associate Professor of the Department of Dermatovenereology and Cosmetology

Bldg. 1A, 19 Marshal Timoshenko, Moscow, 121359

aby@rinet.ruФедеральное государственное бюджетное учреждение дополнительного профессионального образования «Центральная государственная медицинская академия» Управления делами Президента Российской ФедерацииРоссияFederal State Budgetary Institution of Further Professional Education “Central State Medical Academy” of the Administrative Directorate of the President of the Russian FederationRussian Federation201819012019021146151Copyright © Яковлев А.Б., 20192019Яковлев А.Б.Yakovlev A.В.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2829

Микозы кожи стоп – одна из наиболее актуальных проблем в дерматовенерологии вследствие чрезвычайной распространенности этих заболеваний. Лечение микозов кожи стоп – наиболее важный этап профилактики онихомикоза. Тактика и последовательность назначения средств наружной терапии зависят от конкретной клинической формы микоза: островоспалительные формы требуют назначения растворов и гелей, подострые – кремов, хронические – средств на клеевой основе. Экссудативная форма микоза кожи стоп с везикуляцией – показание для назначения комбинированной терапии.

Foot skin mycosis is one of the most topical problems in dermatovenerology due to the extreme prevalence of these diseases. Treatment of foot skin mycoses is the most important step in the prevention of onychomycosis. The tactics and a specific sequence of the external therapy depends on the specific clinical form of mycosis: acute inflammatory forms require the prescription of solutions and gels, subacute forms required creams, chronic forms require adhesive agents. Exudative form of the foot skin mycosis with vesiculation is an indication for the combination therapy.

микоз кожи стоптербинафинкомбинированная терапияFoot skin mycosisterbinafinecombination therapyReferencesСергеев А.Ю., Сергеев Ю.В. Грибковые инфекции. Руководство для врачей. 2 изд. М.: Издательство БИНОМ, 2008. 480 с.Sergeev A.Yu., Sergeev Yu.V. Fungal infections. A guide for physicians. 2nd Ed. M.: BINOM Publishing House, 2008. 480 p. (In Russ).Рукавишникова В.М. Микозы стоп. Изд. 2-е, перераб. и доп. М.: ЭликсКом, 2003. 332 с.Rukavishnikova V.M. Sole mycosis. 2nd Ed., revised and updated. M.: ElixKom, 2003. 332 p. (In Russ).Richardson M.D., Warnock D.W. Fungal infection: Diagnosis and Management. 2nd edit. Blackwell Science Ltd., 1997. 249 p.Richardson M.D., Warnock D.W. Fungal infection: Diagnosis and Management. 2nd edit. Blackwell Science Ltd., 1997. 249 p.Principles and practice of clinical mycology. Ed. by C.C. Kibbler, D.W.R. MacKenzie, F.C. Odds. John Wiley & Sons, Chichester. New York – Toronto – Singapore, 1996. 276 p.Principles and practice of clinical mycology. Ed. by C.C. Kibbler, D.W.R. MacKenzie, F.C. Odds. John Wiley & Sons, Chichester. New York – Toronto – Singapore, 1996. 276 p.Sur R., Babad J.M., Garay M., Liebel F.T., Southall M.D. Anti-inflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2-PGE2 pathway. J. Invest. Dermatol. 2008;128(2):336–344.Sur R., Babad J.M., Garay M., Liebel F.T., Southall M.D. Anti-inflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2-PGE2 pathway. J. Invest. Dermatol. 2008;128(2):336–344.Shemer A., Gupta A.K., Kamshov A., Babaev M., Farhi R., Daniel C.R. 3rd, Foley K.A. Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure. Dermatologic Therapy. 2017 Sep;30(5). doi: 10.1111/dth.12545.Shemer A., Gupta A.K., Kamshov A., Babaev M., Farhi R., Daniel C.R. 3rd, Foley K.A. Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure. Dermatologic Therapy. 2017 Sep;30(5). doi: 10.1111/dth.12545.Ferreirós M.P., García-Martínez F.J., AlonsoGonzález J. Update on the treatment of superficial mycoses. Actas Dermo-Sifiliográficas. 2012; 103(9):778–783.Ferreirós M.P., García-Martínez F.J., AlonsoGonzález J. Update on the treatment of superficial mycoses. Actas Dermo-Sifiliográficas. 2012; 103(9):778–783.Разнатовский К.И., Родионов А.Н., Котрехова Л.П. Дерматомикозы. Руководство для врачей. СПб: Издательский дом СПбМАПО, 2006. 184 с.Raznatovsky K.I., Rodionov A.N., Kotrekhova L.P. Dermatomycosis. A guide for practitioners. SPb: SPbMAPO Publishing House, 2006. 184 p. (In Russ).Täuber A., Müller-Goymann C.C. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model. Molecular Pharmaceutics. 2014 Jul 7;11(7):1991-1996. doi: 10.1021/mp400711q.Täuber A., Müller-Goymann C.C. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model. Molecular Pharmaceutics. 2014 Jul 7;11(7):1991-1996. doi: 10.1021/mp400711q.Petranyi G., Meingassner J.G., Mieth H. Antifungal activity of the allylamine derivate terbinafine in vitro. Antimicrobial Agents and Chemotherapy. 1987 Sep;31(9):1365-1368.Petranyi G., Meingassner J.G., Mieth H. Antifungal activity of the allylamine derivate terbinafine in vitro. Antimicrobial Agents and Chemotherapy. 1987 Sep;31(9):1365-1368.Kyle A.A., Dahl M.V. Topical therapy for fungal infections. American Journal of Clinical Dermatology. 2004;5(6):443-451. Review.Kyle A.A., Dahl M.V. Topical therapy for fungal infections. American Journal of Clinical Dermatology. 2004;5(6):443-451. Review.Korting H.C., Tietz H.J., Brautigam M. et al. One week terbinafine 1 % cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. Medical Mycology. 2001;39:335-340.Korting H.C., Tietz H.J., Brautigam M. et al. One week terbinafine 1 % cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. Medical Mycology. 2001;39:335-340.Иванова Н.Н., Частий Т.В. Липосомальный тербинафин с олеиновой кислотой для грибов Malassezia spp. Успехи медицинской микологии. 2017;17(17):39-41.Ivanova N.N., Chastiy T.V. Liposomal terbinafine with oleic acid for fungi Malassezia spp. Uspekhi Meditsinskoi Mikologii. 2017; 17 (17): 39-41. (In Russ).Noli C., Sartori R., Cena T. Impact of a terbinafine – florfenicol – betamethasone acetate otic gel on the quality of life of dogs with acute otitis externa and their owners. Veterinary Dermatology. 2017 Aug; 28(4):386-390. doi: 10.1111/vde.12433.Noli C., Sartori R., Cena T. Impact of a terbinafine – florfenicol – betamethasone acetate otic gel on the quality of life of dogs with acute otitis externa and their owners. Veterinary Dermatology. 2017 Aug; 28(4):386-390. doi: 10.1111/vde.12433.Hay R. Lamisil: Evidence. New York, London, 2001. 120 p.Hay R. Lamisil: Evidence. New York, London, 2001. 120 p.Saeheng S., Nosoongnoen W., Varothai S, Sathirakul K. In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream. Drug Development and Industrial Pharmacy. 2013 Sep;39(9):1372-1377. doi: 10.3109/03639045.2012.718786.Saeheng S., Nosoongnoen W., Varothai S, Sathirakul K. In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream. Drug Development and Industrial Pharmacy. 2013 Sep;39(9):1372-1377. doi: 10.3109/03639045.2012.718786.Нолтинг С., Браутигам М. Клиническая значимость антимикробной активности тербинафина. Проблемы медицинской микологии. 2005;7(2):17-20.Nolting S., Brautigam M. Clinical significance of the antimicrobial activity of terbinafine. Problemi Meditsinskoi Mikologii. 2005; 7 (2): 17-20. (In Russ)

The authors declare that there are no conflicts of interest present.